Suppliers / Qingdao Jiulong Biopharmaceutical

Qingdao Jiulong Biopharmaceutical

China Updated 9 July 2026

Qingdao Jiulong Biopharmaceutical is an API manufacturer based in China. It holds one active US drug master file. Its most recent recorded inspection, by US FDA, closed on 13 March 2015 as NAI.

1
active US DMFs
0
valid CEPs
1
registered plants 1 with an FDA FEI number
0
filings across 0 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
3 of 3 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.

Inspection history

  • 13 March 2015 NAI US FDA
  • 18 March 2011 VAI US FDA
  • 23 November 2009 OAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
China, China 3006745882

What they file, and where

Molecule Regulators Docs
Heparin Sodium US FDA 1

Also appears on these molecule pages

Heparin API

Questions about Qingdao Jiulong Biopharmaceutical

Does Qingdao Jiulong Biopharmaceutical hold a US DMF or a CEP?
Qingdao Jiulong Biopharmaceutical holds 1 active US drug master file. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
Is Qingdao Jiulong Biopharmaceutical FDA-registered?
One site operated by Qingdao Jiulong Biopharmaceutical carries an FDA establishment identifier (FEI), which means it is registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
How did Qingdao Jiulong Biopharmaceutical's last inspection go?
The most recent inspection on record closed on 13 March 2015 as NAI (No Action Indicated: nothing objectionable was found). 3 inspections are on file, of which 1 closed as OAI.
Where does Qingdao Jiulong Biopharmaceutical manufacture?
1 registered site is on record, in China (China). Every site is listed on this page with the register it came from.
What does Qingdao Jiulong Biopharmaceutical make?
1 molecule is on record against Qingdao Jiulong Biopharmaceutical, including Heparin Sodium. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Qingdao Jiulong Biopharmaceutical comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was NAI, on 13 March 2015.

Comparable suppliers

Gland Pharma shares 1 molecule Sandoz shares 1 molecule Leo Pharma shares 1 molecule Dongying Tiandong Pharmaceutical shares 1 molecule Hebei Changshan Biochemical Pharmaceutical shares 1 molecule

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability